DrugPatentWatch Database Preview

CYSVIEW KIT Drug Profile

« Back to Dashboard

Which patents cover Cysview Kit, and when can generic versions of Cysview Kit launch?

Cysview Kit is a drug marketed by Photocure Asa and is included in one NDA. There is one patent protecting this drug.

This drug has ten patent family members in eight countries.

The generic ingredient in CYSVIEW KIT is hexaminolevulinate hydrochloride. One supplier is listed for this compound. Additional details are available on the hexaminolevulinate hydrochloride profile page.

Summary for CYSVIEW KIT

International Patents:	10
US Patents:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	42
Clinical Trials:	3
Patent Applications:	17
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CYSVIEW KIT
DailyMed Link:	CYSVIEW KIT at DailyMed

Generic Entry Opportunity Date for CYSVIEW KIT

Constraining patent/regulatory exclusivity:

ADDITIONAL INFORMATION ADDED TO THE LABELING FROM STUDY PC B308/13 REGARDING THE USE OF BLUE LIGHT CYSTOSCOPY WITH CYSVIEW AS AN ADJUNCT TO WHITE LIGHT CYSTOSCOPY

NDA:

022555

Dosage:

FOR SOLUTION;INTRAVESICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Synonyms for CYSVIEW KIT

140898-91-5

5-amino-4-oxopentanoic acid hexyl ester hydrochloride

5-Aminolevulinic acid hexyl ester hydrochloride

5-Aminolevulinic acid hexylester hydrochloride

6842AA

898A915

A-6140

AC1O5FJ4

AK-59194

AKOS016002051

ala hexyl ester hydrochloride

AM84373

aminolevulinc acid hexyl ester

aminolevulinic acid hexyl ester hydrochloride

AN-31604

ANW-58882

AX8102340

C11H22ClNO3

CHEMBL1201785

CS-5206

CTK8B7894

Cysview

Cysview (TN)

D04436

D0AY9Q

D4F329SL1O

DB-063352

delta-aminolevulinic acid hexyl ester hydrochloride

DTXSID80161486

FT-0767765

Hexaminolevulinate (hydrochloride)

hexaminolevulinate HCl

Hexaminolevulinate Hydrochloride

Hexaminolevulinate hydrochloride (USAN)

Hexaminolevulinate Hydrochloride [USAN]

Hexaminolevulinate hydrochloride, >=98% (HPLC)

HexvisR

Hexvix

Hexvix (TN)

hexyl 5-amino-4-oxo-pentanoate hydrochloride

Hexyl 5-amino-4-oxopentanoate hydrochloride

hexyl aminolevulinate

HY-16045

LZYXPFZBAZTOCH-UHFFFAOYSA-N

MFCD03695491

MolPort-016-582-410

n-hexyl 5-aminolevulinate hydrochloride

OR1924

P 1206

P-1026

P-1206

Pentanoic acid, 5-amino-4-oxo-, hexyl ester, hydrochloride

SCHEMBL937621

TC-147627

UNII-D4F329SL1O

ZX-AT022126

US Patents and Regulatory Information for CYSVIEW KIT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Photocure Asa	CYSVIEW KIT	hexaminolevulinate hydrochloride	FOR SOLUTION;INTRAVESICAL	022555-001	May 28, 2010		RX	Yes	Yes			Y
Photocure Asa	CYSVIEW KIT	hexaminolevulinate hydrochloride	FOR SOLUTION;INTRAVESICAL	022555-001	May 28, 2010		RX	Yes	Yes

Expired US Patents for CYSVIEW KIT

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Photocure Asa	CYSVIEW KIT	hexaminolevulinate hydrochloride	FOR SOLUTION;INTRAVESICAL	022555-001	May 28, 2010
Photocure Asa	CYSVIEW KIT	hexaminolevulinate hydrochloride	FOR SOLUTION;INTRAVESICAL	022555-001	May 28, 2010
Photocure Asa	CYSVIEW KIT	hexaminolevulinate hydrochloride	FOR SOLUTION;INTRAVESICAL	022555-001	May 28, 2010

International Patents for CYSVIEW KIT

Country	Document Number	Estimated Expiration
Japan	2010163445
Japan	4630395
European Patent Office	1073472
Canada	2327393